Comparison of morphological effects of PGE2 and TGFβ on osteoclastogenesis induced by RANKL in mouse bone marrow cell cultures

Cell and Tissue Research

Volumn 330, Issue 1, 2007, Pages 111-121

  Gardner, Colin R ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Cell culture; Morphology; Mouse (CD 1); Osteoclastogenesis; Prostaglandin E2; Receptor activator of nuclear factor kappa B ligand; Transforming growth factor beta

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL COUNT; CELL CULTURE; CELL DENSITY; CELL DIFFERENTIATION; CELL FUSION; CELL SIZE; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; FEMALE; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; STELLATE CELL;

ANIMALS; BONE MARROW CELLS; CELL NUCLEUS; CELLS, CULTURED; DINOPROSTONE; FEMALE; MICE; OSTEOCLASTS; OSTEOGENESIS; RANK LIGAND; TRANSFORMING GROWTH FACTOR BETA;

EID: 34548777029     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-007-0450-2     Document Type: Article

References (34)

1. Blanqué R, Gardner CR (2000) TNF induces osteoclastogenesis in mouse spleen cell cultures independent of T cells or of RANK ligand. J Bone Miner Res 15 (Suppl 1):S389
2. Chambers TJ, McSheehy PM, Thomson BM, Fuller K (1985) The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology 116:234-239
3. Fox SW, Lovibond AC (2005) Current insights into the role of transforming growth factor-beta in bone resorption. Mol Cell Endocrinol 243:19-26
4. Fujita D, Yamashita N, Iita S, Amano H, Yamada S, Sakamoto K (2003) Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells. Prostaglandins Leukot Essent Fatty Acids 68:351-358
5. Fuller K, Chambers TJ (1989) Effect of arachidonic acid metabolites on bone resorption by isolated rat osteoclasts. J Bone Miner Res 4:209-215
6. Fuller K, Lean JM, Bayley KE, Wani MR, Chambers TJ (2000) A role for TGFbeta(1) in osteoclast differentiation and survival. J Cell Sci 113:2445-2453
7. Fuller K, Kirstein B, Chambers TJ (2006) Murine osteoclast formation and function: differential regulation by humoral agents. Endocrinology 147:1979-1985
8. Gardner CR (2007) Morphological analysis of osteoclastogenesis induced by RANKL in mouse bone marrow cell cultures. Cell Biol Int 31:672-682
9. Gardner CR, Blanqué R, Cottereaux C (2001) Mechanisms involved in prostaglandin-induced increase in bone resorption in neonatal mouse calvaria. Prostaglandins Leukot Essent Fatty Acids 64:117-125
10. Gardner CR, Soria J, Gardner M (2007) Morphological studies of osteoclast apoptosis and the effects of endogenous mediators. In: Cho DW (ed) Focus on cell aoptosis research. Nova, Carondale, Ill. (in press; ISBN 1-60021-433-9)
11. Holloway WR, Collier FM, Herbst RE, Hodge JM, Nicholson GC (1997) Complex shape changes in isolated rat osteoclasts: involvement of protein kinase C in the response to calcitonin. Calcif Tissue Int 61:306-312
12. Itonaga I, Sabokbar A, Sun SG, Kudo O, Danks L, Ferguson D, Fujikawa Y, Athanasou NA (2004) Transforming growth factor-beta induces osteoclast formation in the absence of RANKL. Bone 34:57-64
13. Janssens K, Dijke P ten, Janssens S, Van Hul W (2005) Transforming growth factor-beta1 to the bone. Endocr Rev 26:743-774
14. Jurdic P, Saltel F, Chabadel A, Destaing O (2006) Podosome and sealing zone: specificity of the osteoclast model. Eur J Cell Biol 85:195-202
15. Karsdal MA, Hjorth P, Henriksen K, Kirkegaard T, Nielsen KL, Lou H, Delaissé JM, Foged NT (2003) Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. J Biol Chem 278:44975-44987
16. Karst M, Gorny G, Galvin RJ, Oursler MJ (2004) Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. J Cell Physiol 200:99-106
17. Kim N, Kadono Y, Takami M, Lee J, Okada F, Kim JH, Kobayashi T, Odgren PR, Nakano H, Yeh WC, Lee SK, Lorenzo JA, Choi Y (2005) Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 202:589-595
18. Kobayashi Y, Mizoguchi T, Take I, Kurihara S, Udagawa N, Takahashi N (2005) Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1. J Biol Chem 280:11395-11403
19. Lari R, Fleetwood AJ, Kitchener PD, Cook AD, Pavasovic D, Hertzog PJ, Hamilton JA (2007) Macrophage lineage phenotypes and osteoclastogenesis- complexity in the control by GM-CSF and TGF-beta. Bone 40:323-336
20. Lean JM, Matsuo K, Fox SW, Fuller K, Gibson FM, Draycott G, Wani MR, Bayley KE, Wong BR, Choi Y, Wagner EF, Chambers TJ (2000) Osteoclast lineage commitment of bone marrow precursors through expression of membrane-bound TRANCE. Bone 27:29-40
21. Miyamoto T, Ohneda O, Arai F, Iwamoto K, Okada S, Takagi K, Anderson DM, Suda T (2001) Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98:2544-2554
22. Narayana Murthy PS, Sengupta S, Sharma S, Singh MM (2006) Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression. J Steroid Biochem Mol Biol 100:117-128
23. Ono K, Kaneko H, Choudhary S, Pilbeam CC, Lorenzo JA, Akatsu T, Kugai N, Raisz LG (2005) Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor. J Bone Miner Res 20:23-29
24. Perez-Amodio S, Beertsen W, Everts V (2004) (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts. J Bone Miner Res 19:1722-1731
25. Reddy SV (2004) Regulatory mechanisms operative in osteoclasts. Crit Rev Eukaryot Gene Expr 14:255-270
26. Rivollier A, Mazzorana M, Tebib J, Piperno M, Aitsiselmi T, Rabourdin-Combe C, Jurdic P, Servet-Delprat C (2004) Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104:4029-4037
27. Robinson JA, Riggs BL, Spelsberg TC, Oursler MJ (1996) Osteoclasts and transforming growth factor-beta: estrogen-mediated isoform-specific regulation of production. Endocrinology 137:615-621
28. Takayanagi H (2005) Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med 83:170-179
29. Takita M, Inada M, Maruyama T, Miyaura C (2007) Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse melanoma cells. FEBS Lett 581:565-571
30. Tanaka S, Nakamura K, Takahasi N, Suda T (2005) Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol Rev 208:30-49
31. Tintut Y, Parhami F, Tsingotjidou A, Tetradis S, Territo M, Demer LL (2002) 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem 277:14221-14226
32. Wani MR, Fuller K, Kim NS, Choi Y, Chambers T (1999) Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion. Endocrinology 140:1927-1935
33. Wildemann B, Kadow-Romacker A, Labberstedt M, Rashke M, Haas NP, Schmidmaier G (2005) Differences in the fusion and resorption activity of human osteoclasts after stimulation with different growth factors released from a polylactide carrier. Calcif Tissue Int 76:50-55
34. Yang NN, Bryant HU, Hardikar S, Sato M, Galvin RJ, Glasebrook AL, Termine JD (1996) Estrogen and raloxifene stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance. Endocrinology 137:2075-2084